Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2012 Apr 5.
Published in final edited form as: Biochemistry. 2011 Feb 28;50(13):2550–2558. doi: 10.1021/bi1020106

Dissociation of apoE oligomers to monomers is required for high affinity binding to phospholipid vesicles

Kanchan Garai 1, Berevan Baban 1, Carl Frieden 1
PMCID: PMC3088999  NIHMSID: NIHMS275461  PMID: 21322570

Abstract

The apolipoprotein apoE plays a key role in cholesterol and lipid metabolism. There are three isoforms of this protein, one of which, apoE4, is the major risk factor for Alzheimer's Disease. At μM concentrations all lipid-free apoE isoforms exist primarily as monomers, dimers and tetramers. However, the molecular weight form of apoE that binds to lipid has not been clearly defined. We have examined the role of self-association of apoE with respect to interactions with phospholipids. Measurements of the time dependence of turbidity clearance of small unilamellar vesicles of dimyristoyl-sn-glycero-3-phosphocholine (DMPC) upon addition of apoE show that higher molecular weight oligomers bind poorly if at all. The kinetic data can be described by a reaction model in which tetramers and dimers of apoE must first dissociate to monomers which then bind to the liposome surface in a fast and reversible manner. A slow but not readily reversible conformational conversion of the monomer then occurs. Prior knowledge of the rate constants for the association-dissociation process allows us to determine the rate constant of the conformational conversion. This rate constant is isoform dependent and appears to correlate with the stability of the apoE isoforms with the rate of dissociation of the apoE oligomers to monomers being the rate limiting process for lipidation. Differences in the lipidation kinetics between the apoE isoforms arise from their differences in the self-association behavior leading to the conclusion that self-association behavior may influence biological functions of apoE in an isoform dependent manner.


Apoliprotein E (apoE) is a constituent of several plasma lipoproteins and plays a key role in the metabolism of cholesterol and triglycerides. There are three isoforms of the protein (apoE2, apoE3 and apoE4) that differ only by single amino acid changes. These isoforms differ markedly in their preferences for lipoprotein particles in the plasma and in their receptor binding abilities (1-3). In brief, apoE2 and apoE3 bind preferentially to high density lipoprotein (HDL) particles whereas apoE4 shows high affinity for very low density lipoprotein particles (VLDLs) (4). Additionally, apoE3 and apoE4 bind to low density lipoprotein receptors (LDLR) with high affinity but apoE2 binds only weakly (1-3). Importantly, apoE4 is associated with higher risk for Alzheimer's disease and for cardiovascular disease while apoE2 is associated with hyperlipoproteinamia (3, 5-17). In spite of the profound differences in the outcomes of these diseases, the differences in the molecular properties of the apoE isoforms are still unclear.

The complete structure of lipid-free wild-type ApoE is unknown but the ApoE monomer consists of two domains, an N-terminal domain (residue 1-191) and a C-terminal domain (residue 221-299) (18). The single amino acid changes occur in the N-terminal domain with apoE2 containing two cysteines (C112/C158), apoE4 with arginines replacing the two cysteines (R112/R158) and apoE3 containing a cysteine and an arginine at these two positions (C112/R158). The two domains are linked by a 40 amino acid protease sensitive hinge region. The structure of the N-terminal domain, determined by both X-ray crystallography and solution NMR, consists of a compact four helix bundle (19, 20). The structure of the C-terminal domain has not been determined but is considered to contain extensive helical content. The C-terminal domain is thought to mediate ApoE oligomerization (21-23) and it is believed to contain the major lipid binding site (22). There are extensive domain-domain interactions between the N- and the C-terminal domains in all the isoforms of apoE (24-27).

ApoE undergoes large structural changes upon binding to lipid. X-ray diffraction studies have shown that apoE reorganizes lipid vesicles to disk-like structures with the protein forming a double belt around the lipid disk (28). Low resolution structural characterization of the lipoprotein particles did not detect any differences between the apoE isoforms (29). The kinetics of apoE-phospholipid interactions are found to be isoform specific (30) with differences in the behavior being proposed to be a consequence of differences in the stability of the N-terminal helix bundle of the apoE protein (30). However these differences were observed when only the N-terminal domain of apoE was used rather than the full length protein (30). It is well known that lipid-free apoE undergoes self-association but which molecular weight form of apoE bind to lipids is not known. Several authors have suggested that the self-association might influence lipidation of apoE (31-34). However, this issue has not been explored carefully due to lack of a clear understanding of the self-association behavior of apoE. Since the C-terminal domain of apoE is involved in both self-association and lipid binding, it is likely that these two processes are linked. Hence in order to understand the lipidation process of the apoE isoforms the role of self-association in this process need to be taken into account.

The kinetics of phospholipid solubilization by apoE have been shown to occur in two phases (30). The data have been interpreted with first phase attributed to apoE finding lattice defects in the lipid vesicle and with the second phase being a conformational change during which the N-terminal helix bundle opens to form the belt-like structure (30). Here, we propose a different mechanism to describe the kinetic behavior that involves the dissociation of higher molecular weight species to the monomeric form followed by binding to the lipid. We have recently shown that the self-association behavior of apoE can be described as a monomer-dimer-tetramer process and have determined the association and dissociation rate constants (35). At μM concentrations, where lipid binding experiments are frequently performed, apoE exists primarily as tetramers. Surprisingly, we find that the rate of dissociation of the tetramer to monomer and the rate of reorganization of the lipid by apoE appear to be the same. Thus we suggest that the slow kinetics of lipid binding is a consequence of slow dissociation of the apoE protein and that differences in the lipidation kinetics of the apoE isoforms arise from their differences in the self-association behavior.

MATERIALS AND METHODS

Materials

ApoE was prepared and purified as described previously (27). Site-directed mutations were introduced by QuickChange site-directed mutagenesis kit (Stratagene). The sequences of mutant proteins were verified by DNA sequencing. All chemicals used were Ultrapure from Sigma-Aldrich (St. Louis).

Preparation of unilamellar liposomes

Small unilamellar vesicles (SUV) of dimyristoyl-sn-glycero-3-phosphocholine (DMPC) were prepared by extrusion through 50 nm polycarbonate membranes (Avanti Polar Lipids Inc.) followed by centrifugation at 14 kg. These liposomes, when tested by light scattering, are stable for several days at room temperature.

Passivation of cuvette surface

To avoid adsorption of apoE the inner surface of the quartz cuvette used for fluorescence experiments was passivated according to Selvin and Ha (36). Briefly the cuvette interior was thoroughly cleaned and then functionalized with (3-aminopropyl)triethoxysilane (Sigma). The surface passivation reaction was carried out with methoxy-poly(ethylene glycol)-succinimidyl valerate (mPEG-SVA, Laysan Bio Inc.) in bicarbonate buffer at pH 8.3.

Fluorescence labeling of apoE4

Alanine at position 102 in apoE4 was mutated to cysteine for fluorescent labeling. This single cysteine of apoE4 was labeled by either Alexa488 maleimide or Alexa546 maleimide or pyrene maleimide (Invitrogen). The protein at 2 mg/mL was dissolved in 50 mM HEPES buffer, pH 7.4, 6 M urea, 200 μM tris (2-carboxyethyl)phoshine (TCEP) and then degassed under vacuum for 20 minutes. Alexa488 maleimide or Alexa546 maleimide or pyrene maleimide, 200 μM, was added and the solution kept dark at room temperature under vacuum for 2 h and then at 4 °C overnight. Excess dye was removed by passing the sample over a Superdex200 column in 4 M GdnCl (guanidine-hydrochloride), 20 mM HEPES buffer, pH 7.4, and 0.1% β-mercaptoethanol (βMe). The labeled apoE was then refolded by dialysis against 20 mM HEPES buffer, pH 7.4 and 150 mM NaCl at 4 °C overnight. The absorbance of this sample at 280 nm and 490 nm (for Alexa488) or 555 nm (for Alexa546) or 335 nm (for pyrene) was used to determine the labeled fraction. For all the samples the labeling efficiency was greater than 90%.

Turbidity measurements

Various concentrations of WT apoE4 or apoE3 or apoE2 were added to 3 mL HEPES buffer (20 mM HEPES, 150 mM NaCl, 0.1% βMe and pH 7.4) and let stand at room temperature for 2 hours. DMPC liposomes (final concentration = 0.25 mg/mL) were added to the apoE solutions and the solution stirred continuously throughout the experiments. The turbidity clearance of the DMPC liposomes was performed by monitoring scattering from the sample at 90° to the incident light using an Alphascan fluorometer (Photon Technology International, Inc.) equipped with a programmable shutter. The wavelength of light used in both the excitation and the emission channel was set to 600 nm.

Intermolecular FRET experiments

Separate apoE4-labeled proteins with either Alexa488 or Alexa546 were mixed at a ratio of 1:3 in 4 M GdnCl. This sample was then dialyzed at 4 °C in 20 mM HEPES buffer, pH 7.4 and 150 mM NaCl, flash frozen in liquid nitrogen in small aliquots (100 μL) and then stored at -80 °C prior to use. FRET kinetic experiments were performed using the fluorometer with the excitation and emission monochromators set to 490 nm and 520 nm, respectively. For these experiments different amounts of labeled apoE4 stock solution (from 6 μL to 48 μL of 10μM apoE4) were added into 3 mL buffer containing DMPC liposomes (final conc. = 0.25 mg/mL ) and mixed within 2-3 seconds. The solutions were stirred continuously throughout the experiments. The fluorescence was then monitored for ≈2 h. To prevent photo-bleaching the shutter in the excitation light path was closed between measurements. All experiments performed at 25 °C.

Intramolecular FRET experiments

For the denaturation experiments apoE4 labeled with pyrene at position 102 was diluted into 20 mM HEPES, 150 mM NaCl, 0.1% βMe and pH 7.4 buffer containing varying concentrations of urea. The final apoE concentration was 110 nM. The tryptophan fluorescence at 340 nm with excitation at 290 nm was recorded at each urea concentration. Non-linear least squares fit was performed using Origin 7.0 (Origin Labs, USA) with a two state model using the 6 –term equation adapted from Santoro and Bolen (37). For the kinetic experiments, 110 nM pyrene labeled apoE4(A102C) was added to 3 mL HEPES buffer containing DMPC liposomes (final conc. = 0.25 mg/mL) and mixed within 2-3 seconds. The tryptophan fluorescence was then monitored for ≈2 h. The solution was stirred continuously throughout the experiment. To minimize photo-bleaching the shutter in the excitation light path was closed between measurements. All experiments performed at 25 °C.

Analysis of the kinetic data

The kinetics of lipidation data were analyzed using the model in Scheme 1 by Kintek Explorer (KinTek corporation) (38).

Scheme 1.

Scheme 1

ApoE-lipid interaction model where m1, m2 and m4 represent monomer, dimer and tetramer of apoE respectively. L represents phospholipid. MI is an intermediate and ML is the final lipidated apoE.

Denaturation experiments using circular dichroism

For urea denaturation studies with CD an apoE stock solution (20-30 μM) in Hepes buffer was diluted 10 fold into 20 mM phosphate, pH 7.4 buffer containing varying concentrations of urea. CD spectra were recorded using a Jasco J-715 spectropolarimeter. Twelve scans from 225 nm to 220 nm with speed of 20 nm/minute were averaged for all samples. The fraction (F) of unfolded population was calculated from

F=θθUθNθU (1)

where θ is the CD signal at 222 nm and U and N indicating unfolded and native state, respectively. Non-linear least squares fit is performed using Origin 7.0 (Origin Labs, USA) with a three state model using equation adapted from (39).

RESULTS

Role of self-association in lipidation of apoE

We have previously characterized the concentration dependent self-association behavior of apoE (35). At μM concentrations, tetramers are the dominant species while at lower concentrations (<200 nM) monomers and dimers predominate. However, the dissociation of the tetramers, and specifically the dissociation of dimers to monomers, is a slow process typically taking more than 1 h (35). To test the hypothesis that the oligomeric state of apoE influences its binding to lipid, kinetic experiments were performed with apoE at different starting concentrations (and therefore different oligomeric states) but with the same final concentration. When lipid-free apoE is added to a turbid solution of vesicles of phospholipids, the turbidity decreases in a time dependent manner due to conversion of the vesicles to small disc-like lipoprotein particles (radius ~5-6 nm) induced by apoE (28-30, 40). Figure 1 shows that the rate of turbidity clearance of DMPC liposome solutions upon addition of wild type apoE4 is different depending on the initial concentration of the protein even though the final concentration was the same. Thus, the only difference at time zero is the oligomeric distribution of apoE. When apoE solutions was pre-equilibrated at 65 nM (or at 260 nM) prior to adding the DMPC vesicles the rate of vesicle clearance was faster than when apoE incubated at 27 μM was added to vesicles at the start of the experiements. We interpret the differences in rates to originate from the different initial distribution of oligomeric species. Thus when apoE is preincubated at 65 (or at 260 nM), monomers and dimers predominate while at 27 μM there are only tetramers present (35). This experiment shows that either the monomer or the dimer but not the tetramer interacts with the liposomes.

Figure 1. Effect of apoE self-association state on solubilization of DMPC liposomes.

Figure 1

Turbidity measured by scattering from DMPC liposomes was followed after addition of WT-ApoE4, either equilibrated at the final concentrations (black) or diluted from 27 μM stock solution directly (red) into 0.25 mg/mL DMPC, 20 mM HEPES, 150 mM NaCl, 0.1% βMe, and pH 7.4 buffer. The final concentrations of apoE were 65 nM or 260 nM. Scattering from the sample at 90° to the incident light was monitored at 600 nm.

Reaction scheme of apoE-lipid interactions

A complete reaction scheme for the binding of apoE to lipid would include the possibility that all oligomeric forms of apoE are capable of binding. Figure 1 suggests that the tetrameric forms must dissociate before apoE binding to lipid can occur. This might be an expected result because oligomerization is believed to occur via the C-terminal domain in regions similar to lipid binding domains (22). If we further assume (as discussed later) that dimer formation also involves the same domain, the simplest mechanism would involve only monomer binding to lipid. This mechanism is shown in Scheme 1. In this scheme we include the self-association properties of lipid-free apoE (35). We then assume that only monomers bind to lipids and that the binding process is rapid and reversible. Since it is known that lipid binding leads to transformation of the lipid vesicles to small disk-like particles and a large conformational change in apoE (28) we include an irreversible step to reflect this conformational change. While a detailed mechanism of apoE-lipid interaction is not known, it is generally believed that interaction of apoE to lipoprotein particles occur through two steps. The initial binding (first step) through the C-terminal domain is considered rapid and reversible (30, 41-43). This is followed by opening of the N-terminal helix bundle whereby helix-helix interactions are converted to helix-lipid interactions. This second step is relatively slow and is not readily reversible (43). For simplicity we assumed that the off rate constant (k-c) for this confomational conversion step is sufficiently close to zero that we can set it to zero. As we will show later that this assumption works well to describe the experimental data. We also note that while the actual process of binding to lipids and conformation change of the apoE molecules may occur simultaneously, these processes are treated sequentially in the kinetic scheme. We have previously determined the rate constants (k-1, k+1, k-2, k+2) governing the self-association process under the conditions of these experiments (35). In order to simulate the data the on and off rate constant (k+b and k-b, repectively) for apoE-lipid binding were fixed at 106 M-1s-1 and 1 s-1, values considered to signify that the lipid binding is fast and reversible. The determination of the values of k+b and k-b is beyond the scope of this paper hence these values are somewhat arbitrary. The forward rate constant (k+c) for the conformational change of apoE is unknown and will be determined by experiments given in the subsequent sections.

Comparison of lipidation kinetics with monomer formation

To test the lipidation model proposed in Scheme 1, the kinetics of liposome clearance were compared with the kinetics of dissociation of the tetramers to monomers. Figure 2 shows the kinetic data for liposome clearance by 65 nM apoE4 diluted from a 27 μM stock solution at the start of the experiment. Superimposed is the formation of monomer (squares) calculated using the rate constants for the self-association process of apoE4 determined under the same experimental conditions (35). As discussed above we assumed fast and reversible binding of the monomer to the liposomes. It is clear from Figure 2 that the liposome clearance data correlates well with the formation of monomers from the tetramers.

Figure 2. Comparison of liposome solubilization and dissociation of the tetramers of apoE.

Figure 2

Turbidity measured by scattering (dots) from DMPC liposomes followed by addition of 65 nM WT-apoE4 diluted from 27 μM stock solution into a 0.25 mg/mL DMPC liposome solution in 20 mM HEPES, 150 mM NaCl, 0.1% βMe, and pH 7.4 buffer. The concentration of monomers (□) as a function of time was calculated using previously determined association and dissociation rate constants of lipid-free apoE (35) and assuming fast and reversible binding of the apoE monomer to the liposomes. The kinetic traces were made using Kintek Explorer (Kintek Corporation) (38).

Concentration dependence of apoE self-association

To determine the rate constant for the conformational change of apoE and to test the applicablity of the proposed reaction scheme, the kinetics of apoE-lipid interaction experiments were performed as a function of apoE concentration. Turbidity clearance of DMPC liposomes by various concentrations of apoE4 are shown in Figure 3A. These data show that the rate of turbidity clearance increases as the concentration of apoE decreases. The experimental data can be fit with the reaction scheme presented in Scheme 1. To fit the experimental data the on and off rate constants (k+b and k-b, repectively) for apoE-lipid binding were fixed at 106 M-1s-1 and 1 s-1, as discussed above. Although the values of the association-dissociation rate constants were set according to (35), the best fits were achieved by slight adjustments to the dissociation rate contants (viz, k-2 and k-1). The analysis also allows determination of the forward rate constant of the conformational change (k+c) of the apoE monomer (see Table 1). Similar experiments and analysis performed using apoE3 and apoE2 are shown in Figure 3B and 3C respectively. It is clear that the experimental data agree well with the proposed scheme. The analysis shows that the rate constants for association-dissociation process and for conformational changes of apoE are different for the isoforms (Table 1), indicating isoform specific nature of apoE-lipid interaction. We note here that there are small deviations in the fits at the early time points (<200 s). The cause of this deviation is not clear but may be a consequence of a rapid change in the state of the liposomes immediately after mixing with apoE.

Figure 3. Concentration dependence of turbidity clearance by the apoE isoforms.

Figure 3

Turbidity clearance by 88 nM (□), 176 nM(○), 352 nM (△) and 700 nM (star) WT-apoE4 (A), WT-apoE3 (B) or WT-apoE2 (C) of 0.25 mg/mL DMPC liposome solution in 20 mM HEPES, 150 mM NaCl, 0.1% βMe and pH 7.4 buffer. The solid lines were fit to the data using the model shown in Scheme 1 and the rate constants listed in Table 1. Scattering from the sample at 90° to the incident light was monitored at 600 nm.

Table 1.

Summary of the rate constants§.

Sample k+1 (M-1s-1) k-1 (s-1) k+2 (M-1s-1) k-2 (s-1) k+c (s-1)
WT-apoE4 8.5×103 6.4×10-4 2.0×105 4.0×10-3 2.4±0.2×10-3
WT-apoE3 4.7×103 5.4×10-4 0.8×105 5.0×10-3 2.0±0.2×10-3
WT-apoE2 6.0×103 4.6×10-4 0.8×105 5.0×10-3 1.0±0.2×10-3
§

The rate constants k+b and k-b are fixed at 10 M-1s-1 and 1.0 s-1 respectively.

The values of k+1, k-1, k+2, and k-2 are derived from (35). The value of k-1 for apoE2 was varied by more that 10% to fit the data presented in Figure 3.

Kinetics of dissociation and lipidation using inter-molecular FRET

We have previously used inter-molecular FRET to monitor the rate of dissociation of apoE multimers after dilution and to establish a self-association scheme of lipid-free apoE (35). Since the reaction scheme proposed here is an extension of the reaction scheme of the self-association of lipid-free apoE, we tested the validity of our current model using change in the FRET signal in the presence of DMPC liposomes. In contrast to the turbidity clearance studies, these experiments measure the dissociation of apoE. The changes in the FRET signal at various concentrations of labeled apoE4 in presence of DMPC liposomes are shown in Figure 4. In these experiments apoE4 labeled with either Alexa488 (fluorescence donor) or Alexa546 (fluorescence acceptor) were mixed, equilibrated and diluted in the buffer containing DMPC liposomes, and the fluorescence of Alexa488 was monitored as a function of time. The slow rate of dissociation agrees well with the data presented in Figures 1-3. The solid lines are simulated using the rate constants for apoE4 listed in Table 1. Figure 4 shows that the FRET data are in agreement with the rate constants obtained from the analysis of the turbidity clearance data.

Figure 4. Kinetics of dissociation of Alexa488- and Alexa546- labeled apoE4 in presence of DMPC liposomes using inter-molecular FRET.

Figure 4

Fluorescently labeled apoE4 (15 μM) was diluted to final concentrations of 25 nM (□), 50 nM(○), 100 nM (△) and 200 nM (star) into 0.25 mg/mL DMPC liposome solution in 20 mM HEPES, 150 mM NaCl, 0.1% βMe and pH 7.4 buffer. The molar ratio of Alexa488- and Alexa546 labeled apoE4 (A102C) labeled used was 1:3. The excitation and emission wavelengths were 490 nm and 520 nm. The solid lines were calculated using the rate constants shown in Table 1 for apoE4 by Kintek Explorer (38).

Kinetics of turbidity clearance and the conformational change of apoE

It is known that the apoE undergoes large conformational change on binding to lipid (28). Since apoE monomer contains 7 tryptophan residues in its sequence, 4 in the N-terminal domain and 3 in the C-terminal domain, FRET between the tryptophans and an acceptor dye in a suitable position in the sequence can be used to monitor the conformational changes of the apoE molecule. We have used pyrene labeled apoE4 (A102C) and detected significant amount of FRET signal between the pyrene and the native tryptophan residues.

In order to understand the nature of the structural changes observed by changes in the FRET signal, we performed denaturation of pyrene labeled apoE4 (102C) by monitoring the FRET signal. Figure 5A shows that the tryptophan fluorescence of pyrene labeled apoE4 increases with denaturation by urea, indicating loss of FRET due to denaturation. This is to be expected since the tertiary structure of the protein molecule loses compactness and adopts more extended form. The midpoint of denaturation is ≈ 5 M, close to the denaturation midpoint of the N-terminal domain of apoE4 (44). The observed FRET signal may be a sum of intermolecular, inter-domain or intra-domain energy transfer between the native tryptophans and the pyrene. The FRET signal change at 3 M urea, however, is less than 20% of the total and this urea conscentration is sufficient to unfold the C-terminal domain (44) and to dissociate the multimers of apoE (27). Thus the contributions from self-association and domain-domain proximity are small and the observed FRET can be considered intramolecular involving only the tryptophans of the N-terminal domain. The change in FRET signal may therefore be used to monitor structural unfolding of the N-terminal domain of apoE in presence of the DMPC liposomes.

Figure 5. Denaturation of pyrene labeled apoE measured by FRET and kinetics of lipidation monitored by FRET and turbidity clearance.

Figure 5

A) FRET between pyrene at position 102 and tryptophans in pyrene labeled apoE4 (A102C) as function of urea concentrations (squares). The solid line represents fit to the denaturation data using a two step model according to (37). B) Kinetics of lipidation of pyrene labeled apoE4 (A102C) as monitored by FRET (○) or by turbidity clearance (□). The solid line was calculated from the rate constants for apoE4 as shown in Table 1. The concentration of apoE4 used was 110 nM. FRET signal was monitored at 340 nm with excitation at 290 nm and scattering was monitored at 600 nm.

Figure 5B compares the relation between the kinetics of turbidity clearance (squares) and the kinetics of the conformational changes by intramolecular FRET (circles) due to lipidation of apoE. The observed loss of FRET signal on addition of the protein to the lipid vesicles indicates an increase in distance between the pyrene and the tryptophans at the N-terminal domain of apoE, as the α-helices of the apoE molecules are stretched on the surface of the lipid molecules as opposed to the more compact helix boundle conformation in the lipid-free state (28). It is clear from these data that the kinetics of conformational changes and of the turbidity clearance are essentially identical. In addition, the kinetic data agree well with the rate constants (solid line) as summarized in Table 1.

The forward rate constant of conformational change (k+c) and denaturation stability

To test whether the measured forward rate constants for the conformation change (k+c) of the monomeric apoE molecule can be related to the stabilty of different apoE isoforms we performed denaturation experiments of the apoE isoforms. The urea denaturation profiles of WT apoE4, apoE3 and apoE2, as measured by circular dichroism at 222 nm, are shown in Figure 6. The denaturation data for all the isoforms show three state unfolding behavior corresponding to the unfolding of the C-terminal domain at low urea concentrations followed by the unfolding of the N-terminal domain at higher urea concentrations as has been shown by others (44). The denaturation data are fit according to Morjana et al. (39) using a three state model. It can be seen that the apoE2 is the most stable among all the isoforms followed by apoE3 and apoE4. However the differences in the stabilities between apoE3 and apoE4 appear small. This is in agreement with the measured k+c values (see Table 1) for each of the isoforms where the differences are small between apoE3 and apoE4 but large between apoE2 and the other two isoforms. Hence the rate constant of conformational changes (k+c) of the apoE monomer is correlated with its denaturation stability.

Figure 6. Urea denaturation of apoE isoforms measured by circular dichroism at 222 nm.

Figure 6

The normalized unfolded fraction of apoE is plotted as a functions urea concentration for WT-apoE4 (■), apoE3 (●) and apoE2 (▲). The solid lines are fits to the data using a three state denaturation model according to (39).

DISCUSSION

The reaction scheme of apoE-lipid interaction

The clearance of DMPC liposomes has been shown to occur in two steps (30). The data have previously been intrepreted as a fast binding step followed by a slow conformational change (30). Our data show that this interpretation is incorrect because the role of oligomerization was ignored. Thus, we conclude that the fast phase is a monomer binding step and the slow phase is the dissociation of oligomeric species to the monomer that is then followed by the conformational change. While the kinetic data presented in Figures 1 and 2 support this idea, the reaction mechanism in Scheme 1 can be tested more rigorously by the quantitative analysis of the kinetics of lipidation at various concentrations of apoE. Figures 3A-C, 4 and 5 clearly show that the data are consistent with the proposed model using the previously determined rate constants of association-dissociation processes of apoE. These experiments further enable us to determine the rate constants of conformational changes of apoE molecules on lipid binding.

Only monomer binds to lipids

Our model proposes that only the monomer of apoE binds tightly to the lipid vesicle. Efforts to fit the experimental data shown in Figures 3 and 4 by assuming that only dimers bind to lipids were not successful. However, it is known that there is more than one apoE molecule in a lipoprotein particle. For example, apoE-DPPC particles contain at least two apoE molecules that exist as separate monomers (28). It is possible that after binding to the liposome surface two apoE molecules diffuse closer before formation of the fully formed lipoprotein particle. While our data are consistent with only monomers of apoE binding to lipids, the possibility exists that dimers may bind and then undergo dissociation to monomers on the liposome surface. The kinetic experiments presented here do not distinguish between these two possibilities but it is evident from our data that dissociation of the apoE oligomers to monomers is necessary for formation of the final lipoprotein particles. We also note here that it is possible that multiple binding modes exist for apoE–phospholipid interaction. Hence it is possible that higher ologimers of apoE also bind to lipids but with lower affinity. This is particularly relevant since the isolated N-terminal domain also binds to lipids (30).

Rate limiting factor in the apoE lipid interaction process

As noted earlier, the reaction model in Scheme 1 includes the rate constants for the association-dissociation process and the apoE-lipid interaction process. Modest variations in the values of the association rate constants (k+1 and k+2) and the rate constants for apoE-lipid binding step (k+b and k-b) do not seem to alter the conclusions (data not shown). However, changes in dissociation rate constants of the tetramers and the dimers (k-2 and k-1 respectively) and changes in the forward rate constant of the conformational change of apoE monomer (k+c) do affect the lipidation kinetics significantly. Changes in the lipidation kinetics using the same amount of deviation (± 33%) from the mean value of k-2 or k-1 or k+c are shown in Figure 7A-C, while keeping all the other rate constants same. These plots have been generated by Kintek Explorer (Kintek corporation (38)) at 100 nM apoE4, 0.25 mg/mL DMPC using the rate constants listed in Table 1. It can be seen that changes in k-2 or k-1 or k+c, influence the kinetics with k-1 having the most pronounced effect. Since only the monomers bind to lipids it is intuitive that the dissociation of the dimer to the monomer is the rate limiting step.

Figure 7. The rate determining process in lipidation of apoE.

Figure 7

The kinetics of lipidation of 100 nM apoE4. The solid line is calculated using the rate constants listed in Table 1 for apoE4. The other kinetic plots are calculated assuming a 33% variation in the values of or k-2 (A) or k-1 (B) or k+c (C). It can be seen that dissociation rate constant of dimer to monomer (k-1) has the maximum effect on the overall rate. The kinetic traces are generated using Kintek Explorer (38).

Comparison of the apoE isoforms

The analysis presented here using the mechanism in Scheme 1 makes it possible to separate the contributions of self-association from that of the conformational change. Table 1 shows that the forward rate constant for the conformation conversion of the monomeric form of apoE is isoform specific and that these rate constants appear to be correlated with the relative denaturation stabilities of these proteins. However, it is clear from Figure 7A-C that the dissociation of the dimers to the monomers is the rate determining step at concentrations near or above 100 nM apoE. Table 1 shows that the rate constants for dissociation of dimers to monomers (k-1) are different for the isoforms, being fastest for apoE4 and slowest for apoE2. Hence the the isoform specificity of the kinetics of lipidation is dictated by the isoform specificity of the self-association process. The isoform specific behavior of the kinetics of lipidation has previously been assumed to arise from the isoform specific denaturation stability of the apoE isoforms. This interpretation worked well when only the N-terminal domain (residues 1-191) was used but not when the full length apoE was used (30). We can explain this using our observation that the association-dissociation behavior determines the kinetics of lipidation for the full length apoE but in absence of self assocition which is the case for the N-terminal domain alone the stability of the N-terminal domain would determine the kinetics of lipidation.

Conformational changes and lipidation

As is well known apoE molecules undergo a large confomation reorganization due to lipidation (28). However, the rate of conformational changes and the rate of solubilization of the liposomes have not been previously compared. The data as presented in Figure 5B show that these two processes have similar timescales indicating that the conformational conversion and the formation of the lipidated apoE particles are simultaneous.

Is the interplay of self-association of apoE and the apoE-lipid interaction important in vivo? While lipid-free apoE is not found in the plasma, a large amount of apoE synthesized by the macrophages is thought to be lipid-poor and self-associated (45). ApoE secreted by HEK cells transfected with human apoE is found to be essentially lipid-free and exists as tetramers (46). ATP binding cassette protein ABCA1 which plays important role in the lipidation of apoE binds to lipid-free apoE more efficiently than lipidated apoE (47). In addition lipid-free apoE is biologically active, capable of causing cholesterol efflux and of binding to several cell surface receptors such as ABCA1, lipoprotein receptor related protein (LRP), very low density lipoprotein receptor (VLDL receptor) and heparin sulfate proteoglycans (HSPG) (45, 47-54). These observations indicate that lipid-free apoE is biologically relevant and self-association behavior of lipid-free apoE may have consequences in the lipidation of apoE in vivo. In addition differences in the self-association behavior of the apoE isoforms can explain some of the isoform specific physiological properties of the apoE proteins.

In conclusion, here we present a new scheme to describe the interactions of apoE with phospholipids. In this scheme oligomers of apoE first need to dissociate to monomers before binding to lipids, a step that is then followed by a large conformational reorganization of the monomer. Prior knowledge of the rate constants of self-association of lipid-free apoE (35) enables us to interpret the kinetic data correctly and quantitatively. The data and the analysis presented here will help to advance our understanding of the molecular mechanism of lipoprotein particle formation of apoE and apolipoproteins in general.

ACKNOWLEDGEMENT

We thank Dr. Philip Vergesse for providing expertise with lipids and preparation of liposomes.

FUNDING

This work is supported in part by NIH grant DK13332 and by the Hope Center for Neurological Disorders at Washington University.

ABBREVIATIONS

ApoE

apolipoprotein-E

WT

wild type

GdnCl

guanidine hydrochloride

FRET

fluorescence resonance energy transfer

βMe

β-mercaptoethanol

DMPC

dimyristoyl-sn-glycero-3-phosphocholine

SUV

small unilamellar vesicle

REFERENCES

  • 1.Weisgraber KH, Innerarity TL, Mahley RW. Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site. J Biol Chem. 1982;257:2518–2521. [PubMed] [Google Scholar]
  • 2.Rall SC, Jr., Weisgraber KH, Innerarity TL, Mahley RW. Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects. Proc Natl Acad Sci U S A. 1982;79:4696–4700. doi: 10.1073/pnas.79.15.4696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 1988;8:1–21. doi: 10.1161/01.atv.8.1.1. [DOI] [PubMed] [Google Scholar]
  • 4.Weisgraber KH. Apolipoprotein E distribution among human plasma lipoproteins: role of the cysteine-arginine interchange at residue 112. J Lipid Res. 1990;31:1503–1511. [PubMed] [Google Scholar]
  • 5.Mahley RW, Huang Y, Rall SC., Jr. Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes. J Lipid Res. 1999;40:1933–1949. [PubMed] [Google Scholar]
  • 6.Getz GS, Reardon CA. Apoprotein E as a lipid transport and signaling protein in the blood, liver, and artery wall. J Lipid Res. 2009;50(Suppl):S156–161. doi: 10.1194/jlr.R800058-JLR200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Mahley RW, Weisgraber KH, Huang Y. Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS. J Lipid Res. 2009;50(Suppl):S183–188. doi: 10.1194/jlr.R800069-JLR200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Heide S, Manfred K, Glaser C, Schulz S. Apolipoprotein E (apoE) polymorphism: a risk factor for fatal coronary sclerosis? Forensic Sci Int. 2009;192:62–66. doi: 10.1016/j.forsciint.2009.07.020. [DOI] [PubMed] [Google Scholar]
  • 9.Vaisi-Raygani A, Rahimi Z, Nomani H, Tavilani H, Pourmotabbed T. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients. Clin Biochem. 2007;40:1150–1156. doi: 10.1016/j.clinbiochem.2007.06.010. [DOI] [PubMed] [Google Scholar]
  • 10.Winkler K, Hoffmann MM, Krane V, Marz W, Drechsler C, Wanner C. Apolipoprotein E genotype predicts cardiovascular endpoints in dialysis patients with type 2 diabetes mellitus. Atherosclerosis. 2010;208:197–202. doi: 10.1016/j.atherosclerosis.2009.06.036. [DOI] [PubMed] [Google Scholar]
  • 11.Bennet AM, Di Angelantonio E, Ye Z, Wensley F, Dahlin A, Ahlbom A, Keavney B, Collins R, Wiman B, de Faire U, Danesh J. Association of apolipoprotein E genotypes with lipid levels and coronary risk. Jama. 2007;298:1300–1311. doi: 10.1001/jama.298.11.1300. [DOI] [PubMed] [Google Scholar]
  • 12.Anuurad E, Lu G, Rubin J, Pearson TA, Berglund L. ApoE genotype affects allele-specific apo[a] levels for large apo[a] sizes in African Americans: the Harlem-Basset Study. J Lipid Res. 2007;48:693–698. doi: 10.1194/jlr.M600431-JLR200. [DOI] [PubMed] [Google Scholar]
  • 13.Wagle J, Farner L, Flekkoy K, Wyller TB, Sandvik L, Eiklid KL, Fure B, Stensrod B, Engedal K. Association between ApoE epsilon4 and cognitive impairment after stroke. Dement Geriatr Cogn Disord. 2009;27:525–533. doi: 10.1159/000223230. [DOI] [PubMed] [Google Scholar]
  • 14.Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261:921–923. doi: 10.1126/science.8346443. [DOI] [PubMed] [Google Scholar]
  • 15.Drzezga A, Grimmer T, Henriksen G, Muhlau M, Perneczky R, Miederer I, Praus C, Sorg C, Wohlschlager A, Riemenschneider M, Wester HJ, Foerstl H, Schwaiger M, Kurz A. Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease. Neurology. 2009;72:1487–1494. doi: 10.1212/WNL.0b013e3181a2e8d0. [DOI] [PubMed] [Google Scholar]
  • 16.Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. Jama. 1997;278:1349–1356. [PubMed] [Google Scholar]
  • 17.Alberts MJ, Graffagnino C, McClenny C, DeLong D, Strittmatter W, Saunders AM, Roses AD. ApoE genotype and survival from intracerebral haemorrhage. Lancet. 1995;346:575. doi: 10.1016/s0140-6736(95)91411-0. [DOI] [PubMed] [Google Scholar]
  • 18.Hatters DM, Peters-Libeu CA, Weisgraber KH. Apolipoprotein E structure: insights into function. Trends Biochem Sci. 2006;31:445–454. doi: 10.1016/j.tibs.2006.06.008. [DOI] [PubMed] [Google Scholar]
  • 19.Wilson C, Wardell MR, Weisgraber KH, Mahley RW, Agard DA. Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E. Science. 1991;252:1817–1822. doi: 10.1126/science.2063194. [DOI] [PubMed] [Google Scholar]
  • 20.Sivashanmugam A, Wang J. A unified scheme for initiation and conformational adaptation of human apolipoprotein E N-terminal domain upon lipoprotein binding and for receptor binding activity. J Biol Chem. 2009;284:14657–14666. doi: 10.1074/jbc.M901012200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Aggerbeck LP, Wetterau JR, Weisgraber KH, Wu CS, Lindgren FT. Human apolipoprotein E3 in aqueous solution. II. Properties of the amino- and carboxyl-terminal domains. J Biol Chem. 1988;263:6249–6258. [PubMed] [Google Scholar]
  • 22.Westerlund JA, Weisgraber KH. Discrete carboxyl-terminal segments of apolipoprotein E mediate lipoprotein association and protein oligomerization. J Biol Chem. 1993;268:15745–15750. [PubMed] [Google Scholar]
  • 23.Patel AB, Khumsupan P, Narayanaswami V. Pyrene fluorescence analysis offers new insights into the conformation of the lipoprotein-binding domain of human apolipoprotein E. Biochemistry. 2010;49:1766–1775. doi: 10.1021/bi901902e. [DOI] [PubMed] [Google Scholar]
  • 24.Narayanaswami V, Szeto SS, Ryan RO. Lipid association-induced N-and C-terminal domain reorganization in human apolipoprotein E3. J Biol Chem. 2001;276:37853–37860. doi: 10.1074/jbc.M102953200. [DOI] [PubMed] [Google Scholar]
  • 25.Hatters DM, Budamagunta MS, Voss JC, Weisgraber KH. Modulation of apolipoprotein E structure by domain interaction: differences in lipid-bound and lipid-free forms. J Biol Chem. 2005;280:34288–34295. doi: 10.1074/jbc.M506044200. [DOI] [PubMed] [Google Scholar]
  • 26.Zhang Y, Chen J, Wang J. A complete backbone spectral assignment of lipid-free human apolipoprotein E (apoE) Biomol NMR Assign. 2008;2:207–210. doi: 10.1007/s12104-008-9122-8. [DOI] [PubMed] [Google Scholar]
  • 27.Garai K, Mustafi SM, Baban B, Frieden C. Structural differences between apolipoprotein E3 and E4 as measured by (19)F NMR. Protein Sci. 2010;19:66–74. doi: 10.1002/pro.283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Peters-Libeu CA, Newhouse Y, Hall SC, Witkowska HE, Weisgraber KH. Apolipoprotein E*dipalmitoylphosphatidylcholine particles are ellipsoidal in solution. J Lipid Res. 2007;48:1035–1044. doi: 10.1194/jlr.M600545-JLR200. [DOI] [PubMed] [Google Scholar]
  • 29.Schneeweis LA, Koppaka V, Lund-Katz S, Phillips MC, Axelsen PH. Structural Analysis of Lipoprotein E Particles. Biochemistry. 2005;44:12525–12534. doi: 10.1021/bi050872j. [DOI] [PubMed] [Google Scholar]
  • 30.Segall ML, Dhanasekaran P, Baldwin F, Anantharamaiah GM, Weisgraber KH, Phillips MC, Lund-Katz S. Influence of apoE domain structure and polymorphism on the kinetics of phospholipid vesicle solubilization. J Lipid Res. 2002;43:1688–1700. doi: 10.1194/jlr.m200157-jlr200. [DOI] [PubMed] [Google Scholar]
  • 31.Massey JB, Gotto AM, Jr., Pownall HJ. Human plasma high density apolipoprotein A-I: effect of protein-protein interactions on the spontaneous formation of a lipid-protein recombinant. Biochem Biophys Res Commun. 1981;99:466–474. doi: 10.1016/0006-291x(81)91768-x. [DOI] [PubMed] [Google Scholar]
  • 32.Choy N, Raussens V, Narayanaswami V. Inter-molecular coiled-coil formation in human apolipoprotein E C-terminal domain. J Mol Biol. 2003;334:527–539. doi: 10.1016/j.jmb.2003.09.059. [DOI] [PubMed] [Google Scholar]
  • 33.Lund-Katz S, Phillips MC. High density lipoprotein structure-function and role in reverse cholesterol transport. Subcell Biochem. 51:183–227. doi: 10.1007/978-90-481-8622-8_7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Zhang Y, Vasudevan S, Sojitrawala R, Zhao W, Cui C, Xu C, Fan D, Newhouse Y, Balestra R, Jerome WG, Weisgraber K, Li Q, Wang J. A monomeric, biologically active, full-length human apolipoprotein E. Biochemistry. 2007;46:10722–10732. doi: 10.1021/bi700672v. [DOI] [PubMed] [Google Scholar]
  • 35.Garai K, Frieden C. The Association-Dissociation Behavior of the ApoE Proteins: Kinetic and Equilibrium Studies. Biochemistry. 2010;49:9533–9541. doi: 10.1021/bi101407m. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Selvin PR, Ha T. Single-molecule techniques : a laboratory manual. Cold Spring Harbor Laboratory Press; Cold Spring Harbor, N.Y.: 2008. [Google Scholar]
  • 37.Santoro MM, Bolen DW. Unfolding free energy changes determined by the linear extrapolation method. 1. Unfolding of phenylmethanesulfonyl alpha-chymotrypsin using different denaturants. Biochemistry. 1988;27:8063–8068. doi: 10.1021/bi00421a014. [DOI] [PubMed] [Google Scholar]
  • 38.Johnson KA, Simpson ZB, Blom T. Global kinetic explorer: a new computer program for dynamic simulation and fitting of kinetic data. Anal Biochem. 2009;387:20–29. doi: 10.1016/j.ab.2008.12.024. [DOI] [PubMed] [Google Scholar]
  • 39.Morjana NA, McKeone BJ, Gilbert HF. Guanidine hydrochloride stabilization of a partially unfolded intermediate during the reversible denaturation of protein disulfide isomerase. Proc Natl Acad Sci (USA) 1993;90:2107–2111. doi: 10.1073/pnas.90.6.2107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Pownall H, Pao Q, Hickson D, Sparrow JT, Kusserow SK, Massey JB. Kinetics and mechanism of association of human plasma apolipoproteins with dimyristoylphosphatidylcholine: effect of protein structure and lipid clusters on reaction rates. Biochemistry. 1981;20:6630–6635. doi: 10.1021/bi00526a017. [DOI] [PubMed] [Google Scholar]
  • 41.Jonas A, Drengler SM. Kinetics and mechanism of apolipoprotein A-I interaction with L-alpha-dimyristoylphosphatidylcholine vesicles. J Biol Chem. 1980;255:2190–2194. [PubMed] [Google Scholar]
  • 42.Jonas A, Drengler SM, Patterson BW. Two types of complexes formed by the interaction of apolipoprotein A-I with vesicles of L-alpha-dimyristoylphosphatidylcholine. J Biol Chem. 1980;255:2183–2189. [PubMed] [Google Scholar]
  • 43.Nguyen D, Dhanasekaran P, Phillips MC, Lund-Katz S. Molecular mechanism of apolipoprotein E binding to lipoprotein particles. Biochemistry. 2009;48:3025–3032. doi: 10.1021/bi9000694. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Morrow JA, Segall ML, Lund-Katz S, Phillips MC, Knapp M, Rupp B, Weisgraber KH. Differences in stability among the human apolipoprotein E isoforms determined by the amino-terminal domain. Biochemistry. 2000;39:11657–11666. doi: 10.1021/bi000099m. [DOI] [PubMed] [Google Scholar]
  • 45.Langer C, Huang Y, Cullen P, Wiesenhutter B, Mahley RW, Assmann G, von Eckardstein A. Endogenous apolipoprotein E modulates cholesterol efflux and cholesteryl ester hydrolysis mediated by high-density lipoprotein-3 and lipid-free apolipoproteins in mouse peritoneal macrophages. J Mol Med. 2000;78:217–227. doi: 10.1007/s001090000096. [DOI] [PubMed] [Google Scholar]
  • 46.LaDu MJ, Stine WB, Narita M, Getz GS, Reardon CA, Bu G. Self-Assembly of HEK Cell-Secreted ApoE Particles Resembles ApoE Enrichment of Lipoproteins as a Ligand for the LDL Receptor-Related Protein. Biochemistry. 2006;45:381–390. doi: 10.1021/bi051765s. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Krimbou L, Denis M, Haidar B, Carrier M, Marcil M, Genest J. Molecular interactions between apoE and ABCA1. J Lipid Res. 2004;45:839–848. doi: 10.1194/jlr.M300418-JLR200. [DOI] [PubMed] [Google Scholar]
  • 48.Weisgraber KH, Rall SC, Mahley RW, Milne RW, Marcel YL, Sparrow JT. Human apolipoprotein E. Determination of the heparin binding sites of apolipoprotein E3. J Biol Chem. 1986;261:2068–2076. [PubMed] [Google Scholar]
  • 49.Lin C-Y, Duan H, Mazzone T. Apolipoprotein E-dependent cholesterol efflux from macrophages: kinetic study and divergent mechanisms for endogenous versus exogenous apolipoprotein E. J Lipid Res. 1999;40:1618–1626. [PubMed] [Google Scholar]
  • 50.Bultel-Brienne S. p., Lestavel S, Pilon A, Laffont I, Tailleux A, Fruchart J-C, Siest G. r., Clavey V. r. Lipid Free Apolipoprotein E Binds to the Class B Type I Scavenger Receptor I (SR-BI) and Enhances Cholesteryl Ester Uptake from Lipoproteins. J Biol Chem. 2002;277:36092–36099. doi: 10.1074/jbc.M201943200. [DOI] [PubMed] [Google Scholar]
  • 51.Narita M, Holtzman DM, Fagan AM, LaDu MJ, Yu L, Han X, Gross RW, Bu G, Schwartz AL. Cellular Catabolism of Lipid Poor Apolipoprotein E via Cell Surface LDL Receptor-Related Protein. Journal of Biochemistry. 2002;132:743–749. doi: 10.1093/oxfordjournals.jbchem.a003282. [DOI] [PubMed] [Google Scholar]
  • 52.Ruiz J, Kouiavskaia D, Migliorini M, Robinson S, Saenko EL, Gorlatova N, Li D, Lawrence D, Hyman BT, Weisgraber KH, Strickland DK. The apoE isoform binding properties of the VLDL receptor reveal marked differences from LRP and the LDL receptor. J Lipid Res. 2005;46:1721–1731. doi: 10.1194/jlr.M500114-JLR200. [DOI] [PubMed] [Google Scholar]
  • 53.Yamauchi Y, Deguchi N, Takagi C, Tanaka M, Dhanasekaran P, Nakano M, Handa T, Phillips MC, Lund-Katz S, Saito H. Role of the N- and C-Terminal Domains in Binding of Apolipoprotein E Isoforms to Heparan Sulfate and Dermatan Sulfate: A Surface Plasmon Resonance Study. Biochemistry. 2008;47:6702–6710. doi: 10.1021/bi8003999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Neyen C, Pluddemann A, Roversi P, Thomas B, Cai L, van der Westhuyzen DR, Sim RB, Gordon S. Macrophage Scavenger Receptor A Mediates Adhesion to Apolipoproteins A-I and E. Biochemistry. 2009;48:11858–11871. doi: 10.1021/bi9013769. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES